Valuation Bio-Rad Laboratories, Inc. Deutsche Boerse AG
Stocks
BUWA
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Deutsche Boerse AG
03:55:01 2026-09-04 pm EDT
|
5-day change | 1st Jan Change | ||
| 331.00 EUR | -0.96% |
|
-0.72% | +29.40% |
Company Valuation: Bio-Rad Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,439 | 12,460 | 9,399 | 9,182 | 8,212 | 10,217 | - | - |
| Change | - | -44.47% | -24.57% | -2.31% | -10.57% | 24.42% | - | - |
| Enterprise Value (EV) 1 | 22,439 | 11,868 | 8,992 | 8,730 | 7,874 | 9,468 | 9,252 | 9,111 |
| Change | - | -47.11% | -24.24% | -2.91% | -9.8% | 20.24% | -2.29% | -1.53% |
| P/E | 5.38x | - | -14.8x | -5.03x | 10.9x | 46.4x | 45.4x | 45.7x |
| PBR | - | 1.27x | 1.05x | 1.41x | 1.11x | - | - | - |
| PEG | - | - | - | -0x | -0x | -0.7x | 21.01x | -64.82x |
| Capitalization / Revenue | 7.68x | 4.45x | 3.52x | 3.58x | 3.18x | 3.97x | 3.88x | 3.81x |
| EV / Revenue | 7.68x | 4.24x | 3.37x | 3.4x | 3.05x | 3.68x | 3.51x | 3.4x |
| EV / EBITDA | 33.1x | 17.8x | 16.8x | 18.2x | 17.4x | 23.1x | 21.3x | 20.4x |
| EV / EBIT | 39.3x | 22.7x | 23.7x | 26.4x | 25.3x | 32.9x | 29.1x | 27.7x |
| EV / FCF | 41.9x | 127x | 24x | - | - | 30.8x | 29.3x | 27.5x |
| FCF Yield | 2.39% | 0.79% | 4.17% | - | - | 3.24% | 3.41% | 3.64% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 140.6 | - | -21.82 | -65.36 | 27.85 | 8.33 | 8.51 | 8.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,923 | 2,802 | 2,671 | 2,566 | 2,583 | 2,573 | 2,633 | 2,682 |
| EBITDA 1 | 677.5 | 667.9 | 535.9 | 479.5 | 453.2 | 410.3 | 435 | 446.5 |
| EBIT 1 | 571.2 | 524 | 378.9 | 331.3 | 311.6 | 287.5 | 318.4 | 328.8 |
| Net income 1 | 4,246 | -3,628 | -637.3 | -1,844 | 759.9 | 225 | 230 | 228 |
| Net Debt 1 | - | -592.5 | -407.6 | -452.1 | -337.7 | -749 | -965.4 | -1,107 |
| Reference price 2 | 755.57 | 420.49 | 322.89 | 328.51 | 302.99 | 386.11 | 386.11 | 386.11 |
| Nbr of stocks (in thousands) | 29,918 | 29,824 | 29,145 | 27,997 | 26,975 | 26,738 | - | - |
| Announcement Date | 2/10/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 31.08x | 4.2x | 16.15x | 2.37% | 187B | ||
| 19.92x | 3.63x | 12.95x | 3.01% | 120B | ||
| 18.12x | 0.21x | 13.19x | 0.72% | 63.15B | ||
| 29.59x | 7.29x | 18.82x | 1.35% | 51.75B | ||
| 35.6x | 3.43x | 11.76x | 2.12% | 50.32B | ||
| 35.23x | 6.2x | 19.45x | -.--% | 33.17B | ||
| 47.24x | 1.35x | 12.52x | 0.2% | 32.1B | ||
| 39.65x | 6.94x | 24.91x | 0.27% | 23.93B | ||
| 18.12x | 2.89x | 10.23x | 1.53% | 22.99B | ||
| Average | 30.51x | 4.02x | 15.55x | 1.29% | 65.03B | |
| Weighted average by Cap. | 28.60x | 3.88x | 15.15x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BIO Stock
- BUWA Stock
- Valuation Bio-Rad Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















